Emergent BioSolutions | Чистый Доход





Чистый доход Изменить Дата
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Akebia Therapeutics USD 6.11M 28.92M 2025-03
ALKERMES USD 49.34M 33.42M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amarin USD -7.74M 6.4M 2025-09
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Coherus Biosciences USD -56.57M 5.87M 2025-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Exact Sciences USD -19.59M 18.41M 2025-09
Exelixis USD 193.58M 8.73M 2025-09
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
Lonza CHF 307M 22M 2024-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Myriad Genetics USD -27.4M 303.1M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Pacira USD 1.64M 3.8M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Xoma USD -17.24M 33.23M 2024-09


Emergent BioSolutions Чистый Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2026.